MSCI November Semi-Annual Index Review Announcement Scheduled For November 14, 2016

MSCI Inc. (NYSE: MSCI), a leading provider of research-based indexes and analytics, will announce the results of the November 2016 Semi-Annual Index Review for the MSCI Equity Indexes - including the MSCI Global Standard, MSCI Global Small Cap and MSCI Micro Cap Indexes, the MSCI Global Value and Growth Indexes, the MSCI Frontier Markets and MSCI Frontier Markets Small Cap Indexes, the MSCI Global Islamic and MSCI Global Islamic Small Cap Indexes, the MSCI Pan-Euro and MSCI Euro Indexes, the MSCI US Equity Indexes, the MSCI US REIT Index, and the MSCI China A Indexes. All changes will be made as of the close of November 30, 2016.

MSCI will post the list of additions to and deletions from the indexes for the November 2016 Semi-Annual Index Review on its web site, www.msci.com, shortly after 11:00 p.m. Central European Time (CET) on November 14, 2016.

A summary of the announcement will be made available shortly thereafter on Bloomberg page MSCN, and Reuters public page MSCIA.

Additionally, MSCI will make detailed rebalancing information available to clients beginning immediately after the summary announcement appears on Bloomberg and/or Reuters. Clients can access the subscriber section of each index at: www.msci.com/index-review-subscribers

For the MSCI US Equity Indexes and the MSCI US REIT Index, a summary of the announcement will be made available at www.msci.com.

About MSCI

For more than 40 years, MSCI's research-based indexes and analytics have helped the world's leading investors build and manage better portfolios. Clients rely on our offerings for deeper insights into the drivers of performance and risk in their portfolios, broad asset class coverage and innovative research.

Our line of products and services includes indexes, analytical models, data, real estate benchmarks and ESG research.

MSCI serves 97 of the top 100 largest money managers, according to the most recent P&I ranking.

If you liked this article you might like

Here Is Another Reason Why Blue Apron Is Facing an Investor Backlash

Here Comes a $400 Billion Cash Infusion Into Chinese Stocks, BlackRock Predicts

MSCI Agrees To Include Domestically Listed Chinese Stocks

Young Guns of Activism Join Boards at AIG, SunOpta and DepoMed

How to Trade Wednesday's Most Active Stocks: Lloyds, Arena Pharma, MSCI and More